May 16, 2016 07:35AM
May 13, 2016 11:59AM
May 12, 2016 10:38AM
Apr 18, 2016 10:34AM
Apr 18, 2016 08:53AM
Apr 7, 2016 01:21AM
Apr 7, 2016 01:21AM Mega deals morph into mega problems for Wall Street
Apr 7, 2016 01:21AM
Apr 7, 2016 01:21AM
Apr 7, 2016 01:21AM
Apr 5, 2016 09:13PM
Apr 5, 2016 09:26AM
Apr 5, 2016 06:37AM
Apr 4, 2016 07:05PM Pfizer and Allergan Issue Statement
Mar 30, 2016 12:42PM
Mar 30, 2016 12:41PM
Mar 9, 2016 06:46AM
Mar 9, 2016 06:45AM
Feb 8, 2016 09:46AM
Feb 8, 2016 09:30AM
Jan 25, 2016 07:18AM Johnson Controls to buy Ireland-based Tyco for $16.5 billion
Dec 1, 2015 07:03PM
Nov 26, 2015 02:48PM
Nov 25, 2015 10:28AM
Nov 23, 2015 10:03AM
Nov 23, 2015 07:03AM
Nov 16, 2015 05:18PM
Nov 2, 2015 12:23PM Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks
Mar 26, 2015 10:00AM
Jan 5, 2015 05:27PM
Dec 26, 2014 11:04AM
Jun 30, 2014 10:03AM
Apr 22, 2014 08:44AM
Apr 21, 2014 09:13AM
Mar 12, 2014 03:56PM Goldman Sachs Comments on Pfizer's (PFE) Celebrex Litigation and EPS Impact
Feb 28, 2014 09:02AM
Feb 3, 2014 10:19AM
Dec 3, 2013 08:38AM
Jun 28, 2013 01:09PM
Jun 29, 2012 10:10AM
May 2, 2012 08:38AM
Mar 27, 2012 07:27AM Pfizer (PFE) Can Go Further to Unlock Value - Goldman Sachs
Jan 9, 2012 01:14PM
Nov 2, 2011 12:27PM
Aug 9, 2011 10:55AM
Aug 9, 2011 08:39AM
Apr 25, 2011 08:05AM
May 18, 2009 10:07AM
Mar 5, 2009 10:21AM Notable Analyst Rating Changes 3/5: BIDU, T, ADBE, SIGM Upgraded; CXR, RIO, GPS Downgraded
Mar 5, 2009 07:51AM

19,099 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All